Literature DB >> 22796712

Cost-effectiveness and budget impact analyses of a long-term hypertension detection and control program for stroke prevention.

Kazumasa Yamagishi1, Shinichi Sato, Akihiko Kitamura, Masahiko Kiyama, Takeo Okada, Takeshi Tanigawa, Tetsuya Ohira, Hironori Imano, Masahide Kondo, Ichiro Okubo, Yoshinori Ishikawa, Takashi Shimamoto, Hiroyasu Iso.   

Abstract

OBJECTIVES: The nation-wide, community-based intensive hypertension detection and control program, as well as universal health insurance coverage, may well be contributing factors for helping Japan rank near the top among countries with the longest life expectancy. We sought to examine the cost-effectiveness of such a community-based intervention program, as no evidence has been available for this issue.
METHODS: The hypertension detection and control program was initiated in 1963 in full intervention and minimal intervention communities in Akita, Japan. We performed comparative cost-effectiveness and budget-impact analyses for the period 1964-1987 of the costs of public health services and treatment of patients with hypertension and stroke on the one hand, and incidence of stroke on the other in the full intervention and minimal intervention communities.
RESULTS: The program provided in the full intervention community was found to be cost saving 13 years after the beginning of program in addition to the fact of effectiveness that; the prevalence and incidence of stroke were consistently lower in the full intervention community than in the minimal intervention community throughout the same period. The incremental cost was minus 28,358 yen per capita over 24 years.
CONCLUSION: The community-based intensive hypertension detection and control program was found to be both effective and cost saving. The national government's policy to support this program may have contributed in part to the substantial decline in stroke incidence and mortality, which was largely responsible for the increase in Japanese life expectancy.

Entities:  

Mesh:

Year:  2012        PMID: 22796712     DOI: 10.1097/HJH.0b013e3283568781

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  6 in total

Review 1.  Cardiovascular disease, a major global burden: Epidemiology of stroke and ischemic heart disease in Japan.

Authors:  Hiroyasu Iso
Journal:  Glob Health Med       Date:  2021-12-31

2.  Relationship between outpatient visit frequency and hypertension control: a 9-year occupational cohort study.

Authors:  Azusa Shima; Yukako Tatsumi; Tatsuro Ishizaki; Kayo Godai; Yuichiro Kawatsu; Tomonori Okamura; Tomofumi Nishikawa; Akiko Morimoto; Ayumi Morino; Naomi Miyamatsu
Journal:  Hypertens Res       Date:  2016-01-14       Impact factor: 3.872

3.  The Circulatory Risk in Communities Study (CIRCS): A Long-Term Epidemiological Study for Lifestyle-Related Disease Among Japanese Men and Women Living in Communities.

Authors:  Kazumasa Yamagishi; Isao Muraki; Yasuhiko Kubota; Mina Hayama-Terada; Hironori Imano; Renzhe Cui; Mitsumasa Umesawa; Yuji Shimizu; Tomoko Sankai; Takeo Okada; Shinichi Sato; Akihiko Kitamura; Masahiko Kiyama; Hiroyasu Iso
Journal:  J Epidemiol       Date:  2018-12-22       Impact factor: 3.211

Review 4.  Systematic Review of the Effectiveness of Community Intervention and Health Promotion Programs for the Prevention of Non-Communicable Diseases in Japan and Other East and Southeast Asian Countries.

Authors:  Akihiro Hirashiki; Atsuya Shimizu; Kenichiro Nomoto; Manabu Kokubo; Noriyuki Suzuki; Hidenori Arai
Journal:  Circ Rep       Date:  2022-03-29

5.  Cost-Effectiveness Analysis of Screening for and Managing Identified Hypertension for Cardiovascular Disease Prevention in Vietnam.

Authors:  Thi-Phuong-Lan Nguyen; E Pamela Wright; Thanh-Trung Nguyen; C C M Schuiling-Veninga; M J Bijlsma; Thi-Bach-Yen Nguyen; M J Postma
Journal:  PLoS One       Date:  2016-05-18       Impact factor: 3.240

Review 6.  A Systematic Review of Economic Evidence on Community Hypertension Interventions.

Authors:  Donglan Zhang; Guijing Wang; Heesoo Joo
Journal:  Am J Prev Med       Date:  2017-12       Impact factor: 5.043

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.